A Yale researcher is recipient of a $100,000 grant from the National Alliance for Research on Schizophrenia and Depression (NARSAD) for a project focusing on new antidepressant targets in the brain.
The Independent Investigator grant awarded to Marina Picciotto, associate professor of psychiatry, pharmacology and neurobiology at Yale School of Medicine, is provided to scientists who have already won national competitive support as principal investigators. Picciotto will study the antidepressant effect of blocking the nicotinic acetylcholine receptor.
NARSAD is a nonprofit charitable organization that raises funds from individuals, corporations and foundations. It does not accept government funding. Since its founding in 1987, NARSAD has raised more than $162.1 million and has funded more than 2,400 research projects.
